{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:08:51Z","timestamp":1791407331207,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1378\/chest.08-1323","type":"journal-article","created":{"date-parts":[[2008,8,22]],"date-time":"2008-08-22T01:31:43Z","timestamp":1219368703000},"page":"130-136","source":"Crossref","is-referenced-by-count":50,"title":["Hemodynamics and Epoprostenol Use Are Associated With Thrombocytopenia in Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"135","author":[{"given":"Kelly M.","family":"Chin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Channick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis J.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.08-1323_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol with conventional therapy in primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-1323_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(89)90236-7","article-title":"Human endothelial cells inhibit platelet aggregation by stimulating cAMP and cGMP","volume":"164","author":"Alheid","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1378\/chest.08-1323_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/bj3230371","article-title":"Activation of cGMP stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelets aggregation","volume":"323","author":"Dickinson","year":"1997","journal-title":"Biochem J"},{"key":"10.1378\/chest.08-1323_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1183\/09031936.02.00094302","article-title":"Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation","volume":"19","author":"Beghetti","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.08-1323_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-134-4-200102200-00030","article-title":"Drug-induced thrombocytopenia: an updated systematic review","volume":"134","author":"Rizvi","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-1323_bib6","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1055\/s-0028-1104277","article-title":"Frequency and pathogenesis of thrombocytopenia in cardiac failure [in German]","volume":"101","author":"Heck","year":"1976","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1378\/chest.08-1323_bib7","first-page":"2580","article-title":"Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis","volume":"91","author":"Shah","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1378\/chest.08-1323_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1183\/09031936.06.00095705","article-title":"A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension","volume":"27","author":"Robbins","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.08-1323_bib9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1378\/chest.95.6.1207","article-title":"Effect of intentional hemodilution on platelet survival in secondary pulmonary hypertension","volume":"95","author":"Lopes","year":"1989","journal-title":"Chest"},{"key":"10.1378\/chest.08-1323_bib10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archinte.1991.00400060133023","article-title":"Primary pulmonary hypertension: its association with microangiopathic hemolytic anemia and thrombocytopenia","volume":"151","author":"Jubelirer","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-1323_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1183\/09031936.93.04020147","article-title":"Evidence for local platelet activation in pulmonary vessels in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease","volume":"4","author":"Rostagno","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.08-1323_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.55.4.660","article-title":"Platelet survival time in patients with hypoxemia and pulmonary hypertension","volume":"55","author":"Steele","year":"1977","journal-title":"Circulation"},{"key":"10.1378\/chest.08-1323_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/cvr\/16.7.391","article-title":"Platelet kinetics in congenital heart disease","volume":"16","author":"Peters","year":"1982","journal-title":"Cardiovasc Res"},{"key":"10.1378\/chest.08-1323_bib14","first-page":"105","article-title":"Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease","volume":"18","author":"Zahavi","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-1323_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/lt.500050517","article-title":"Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension","volume":"5","author":"Findlay","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1378\/chest.08-1323_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.117.1.14","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus","volume":"117","author":"Robbins","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.08-1323_bib17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1378\/chest.118.4.1229","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus","volume":"118","author":"Horn","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.08-1323_bib18","doi-asserted-by":"crossref","first-page":"760S","DOI":"10.1378\/chest.126.4_MeetingAbstracts.760S-b","article-title":"Thrombocytopenia associated with chronic intravenous epoprostenol therapy [abstract]","volume":"126","author":"Hargett","year":"2004","journal-title":"Chest"},{"key":"10.1378\/chest.08-1323_bib19","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1161\/01.CIR.96.9.2782","article-title":"Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension","volume":"96","author":"Friedman","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.08-1323_bib20","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/01.CIR.102.22.2720","article-title":"Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy","volume":"102","author":"Sakamaki","year":"2000","journal-title":"Circulation"},{"key":"10.1378\/chest.08-1323_bib21","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1046\/j.1525-1594.1999.06452.x","article-title":"The effect of epoprostenol on platelet activation and consumption during experimental extracorporeal perfusion","volume":"23","author":"Skogby","year":"1999","journal-title":"Artif Organs"},{"key":"10.1378\/chest.08-1323_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1055\/s-0038-1665335","article-title":"The behaviour of various platelet function tests during long-term prostacyclin infusion in patients with peripheral vascular disease","volume":"50","author":"Sinzinger","year":"1983","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-1323_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/000331978503600409","article-title":"Thrombocytopenia and lupus-like anticoagulant in a patient with peripheral vascular disease: response to infusion of prostacyclin","volume":"36","author":"Fonseca","year":"1985","journal-title":"Angiology"},{"key":"10.1378\/chest.08-1323_bib24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood.V90.3.1039","article-title":"Expression of prostacyclin receptor in human megakaryocytes","volume":"99","author":"Sasaki","year":"1997","journal-title":"Blood"},{"key":"10.1378\/chest.08-1323_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jcp.1041630327","article-title":"Cyclic-AMP inhibits cell growth and negatively interacts with platelet membrane glycoprotein expression on the Dami human megakaryoblastic cell line","volume":"163","author":"Vittet","year":"1995","journal-title":"J Cell Physiol"},{"key":"10.1378\/chest.08-1323_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.prostaglandins.2007.01.012","article-title":"The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells","volume":"83","author":"Shen","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1378\/chest.08-1323_bib27","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/rccm.200505-766OC","article-title":"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension","volume":"172","author":"Gomberg-Maitland","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.08-1323_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1378\/chest.07-1992","article-title":"Transition from IV to subcutaneous prostacyclin: premature withdrawal?","volume":"132","author":"Shapiro","year":"2007","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369209600775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369209600775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T18:03:19Z","timestamp":1684519399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369209600775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0012369209600775"],"URL":"https:\/\/doi.org\/10.1378\/chest.08-1323","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}